Cytokinetics, Incorporated (CYTK)
USD 37.12
(-8.39%)
USD 37.12
(-8.39%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.21 Billion USD | 7.84% |
| 2022 | 1.12 Billion USD | 87.91% |
| 2021 | 597.45 Million USD | 42.11% |
| 2020 | 420.42 Million USD | 39.79% |
| 2019 | 300.75 Million USD | 62.35% |
| 2018 | 185.24 Million USD | 0.15% |
| 2017 | 184.96 Million USD | 144.08% |
| 2016 | 75.78 Million USD | 62.46% |
| 2015 | 46.64 Million USD | 14.04% |
| 2014 | 40.9 Million USD | 42.29% |
| 2013 | 28.74 Million USD | 370.4% |
| 2012 | 6.11 Million USD | 32.99% |
| 2011 | 4.59 Million USD | -38.54% |
| 2010 | 7.47 Million USD | -64.69% |
| 2009 | 21.17 Million USD | -43.83% |
| 2008 | 37.68 Million USD | -32.04% |
| 2007 | 55.45 Million USD | -12.26% |
| 2006 | 63.2 Million USD | 253.09% |
| 2005 | 17.9 Million USD | -12.87% |
| 2004 | 20.54 Million USD | -86.74% |
| 2003 | 154.9 Million USD | 32.67% |
| 2002 | 116.75 Million USD | 0.33% |
| 2001 | 116.37 Million USD | 40.45% |
| 2000 | 82.85 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.2 Billion USD | -0.53% |
| 2024 Q2 | 1.41 Billion USD | 17.52% |
| 2023 Q3 | 1.17 Billion USD | 5.97% |
| 2023 Q4 | 1.21 Billion USD | 2.65% |
| 2023 FY | 1.21 Billion USD | 7.84% |
| 2023 Q1 | 1.11 Billion USD | -0.34% |
| 2023 Q2 | 1.11 Billion USD | -0.52% |
| 2022 Q3 | 1.09 Billion USD | 65.37% |
| 2022 Q2 | 660.3 Million USD | -10.77% |
| 2022 Q1 | 739.99 Million USD | 23.86% |
| 2022 FY | 1.12 Billion USD | 87.91% |
| 2022 Q4 | 1.12 Billion USD | 2.81% |
| 2021 Q3 | 578.51 Million USD | 5.61% |
| 2021 FY | 597.45 Million USD | 42.11% |
| 2021 Q1 | 509.21 Million USD | 21.12% |
| 2021 Q2 | 547.81 Million USD | 7.58% |
| 2021 Q4 | 597.45 Million USD | 3.27% |
| 2020 Q1 | 302.29 Million USD | 0.51% |
| 2020 FY | 420.42 Million USD | 39.79% |
| 2020 Q4 | 420.42 Million USD | 29.56% |
| 2020 Q3 | 324.5 Million USD | 4.49% |
| 2020 Q2 | 310.57 Million USD | 2.74% |
| 2019 Q1 | 195.23 Million USD | 5.4% |
| 2019 Q3 | 207.26 Million USD | 2.04% |
| 2019 Q4 | 300.75 Million USD | 45.11% |
| 2019 FY | 300.75 Million USD | 62.35% |
| 2019 Q2 | 203.11 Million USD | 4.03% |
| 2018 FY | 185.24 Million USD | 0.15% |
| 2018 Q1 | 180.32 Million USD | -2.51% |
| 2018 Q3 | 178.21 Million USD | 3.57% |
| 2018 Q2 | 172.06 Million USD | -4.58% |
| 2018 Q4 | 185.24 Million USD | 3.95% |
| 2017 Q4 | 184.96 Million USD | 3.18% |
| 2017 FY | 184.96 Million USD | 144.08% |
| 2017 Q1 | 169.99 Million USD | 124.32% |
| 2017 Q2 | 165.62 Million USD | -2.57% |
| 2017 Q3 | 179.27 Million USD | 8.24% |
| 2016 Q1 | 55.31 Million USD | 18.58% |
| 2016 FY | 75.78 Million USD | 62.46% |
| 2016 Q4 | 75.78 Million USD | 1.15% |
| 2016 Q2 | 57.41 Million USD | 3.8% |
| 2016 Q3 | 74.92 Million USD | 30.49% |
| 2015 Q2 | 37.84 Million USD | -0.57% |
| 2015 Q3 | 34.89 Million USD | -7.79% |
| 2015 Q4 | 46.64 Million USD | 33.67% |
| 2015 FY | 46.64 Million USD | 14.04% |
| 2015 Q1 | 38.06 Million USD | -6.95% |
| 2014 Q3 | 13.55 Million USD | -22.3% |
| 2014 Q4 | 40.9 Million USD | 201.76% |
| 2014 FY | 40.9 Million USD | 42.29% |
| 2014 Q1 | 21.09 Million USD | -26.6% |
| 2014 Q2 | 17.44 Million USD | -17.31% |
| 2013 Q1 | 6.26 Million USD | 2.44% |
| 2013 Q3 | 48.25 Million USD | 13.37% |
| 2013 Q4 | 28.74 Million USD | -40.43% |
| 2013 FY | 28.74 Million USD | 370.4% |
| 2013 Q2 | 42.56 Million USD | 579.97% |
| 2012 Q2 | 4.1 Million USD | -9.37% |
| 2012 FY | 6.11 Million USD | 32.99% |
| 2012 Q4 | 6.11 Million USD | 28.87% |
| 2012 Q1 | 4.52 Million USD | -1.55% |
| 2012 Q3 | 4.74 Million USD | 15.66% |
| 2011 Q4 | 4.59 Million USD | -8.72% |
| 2011 FY | 4.59 Million USD | -38.54% |
| 2011 Q2 | 5.5 Million USD | -9.4% |
| 2011 Q1 | 6.07 Million USD | -18.73% |
| 2011 Q3 | 5.03 Million USD | -8.56% |
| 2010 Q1 | 18.25 Million USD | -13.76% |
| 2010 Q4 | 7.47 Million USD | 10.01% |
| 2010 FY | 7.47 Million USD | -64.69% |
| 2010 Q3 | 6.79 Million USD | -7.71% |
| 2010 Q2 | 7.36 Million USD | -59.67% |
| 2009 Q4 | 21.17 Million USD | -2.92% |
| 2009 FY | 21.17 Million USD | -43.83% |
| 2009 Q1 | 45.72 Million USD | 21.33% |
| 2009 Q3 | 21.8 Million USD | -12.79% |
| 2009 Q2 | 25 Million USD | -45.32% |
| 2008 Q2 | 46.77 Million USD | -9.54% |
| 2008 FY | 37.68 Million USD | -32.04% |
| 2008 Q1 | 51.71 Million USD | -6.74% |
| 2008 Q4 | 37.68 Million USD | -11.82% |
| 2008 Q3 | 42.73 Million USD | -8.63% |
| 2007 Q2 | 61.47 Million USD | -5.49% |
| 2007 Q3 | 59.2 Million USD | -3.69% |
| 2007 FY | 55.45 Million USD | -12.26% |
| 2007 Q1 | 65.04 Million USD | 2.92% |
| 2007 Q4 | 55.45 Million USD | -6.33% |
| 2006 Q3 | 19.05 Million USD | 13.54% |
| 2006 Q1 | 15.61 Million USD | -12.75% |
| 2006 FY | 63.2 Million USD | 253.09% |
| 2006 Q4 | 63.2 Million USD | 231.62% |
| 2006 Q2 | 16.78 Million USD | 7.48% |
| 2005 Q2 | 17.34 Million USD | -14.51% |
| 2005 Q3 | 17.67 Million USD | 1.93% |
| 2005 Q4 | 17.9 Million USD | 1.26% |
| 2005 FY | 17.9 Million USD | -12.87% |
| 2005 Q1 | 20.28 Million USD | -1.26% |
| 2004 Q3 | 20.55 Million USD | -4.31% |
| 2004 Q4 | 20.54 Million USD | -0.04% |
| 2004 FY | 20.54 Million USD | -86.74% |
| 2004 Q2 | 21.47 Million USD | -86.01% |
| 2004 Q1 | 153.5 Million USD | -0.91% |
| 2003 Q4 | 154.9 Million USD | 0.0% |
| 2003 FY | 154.9 Million USD | 32.67% |
| 2002 FY | 116.75 Million USD | 0.33% |
| 2001 FY | 116.37 Million USD | 40.45% |
| 2000 FY | 82.85 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -260.55% |
| Alkermes plc | 933.53 Million USD | -29.683% |
| Agenus Inc. | 462.29 Million USD | -161.876% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 70.112% |
| Aptorum Group Limited | 5.25 Million USD | -22930.233% |
| Ardelyx, Inc. | 130.76 Million USD | -825.827% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -153.065% |
| Bicycle Therapeutics plc | 224.41 Million USD | -439.472% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -829.759% |
| ChromaDex Corporation | 26.5 Million USD | -4467.07% |
| Chimerix, Inc. | 19.74 Million USD | -6031.37% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -3341.553% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -1568.305% |
| CRISPR Therapeutics AG | 346.76 Million USD | -249.121% |
| Precision BioSciences, Inc. | 140.92 Million USD | -759.097% |
| Dyadic International, Inc. | 2.34 Million USD | -51622.32% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -7344.131% |
| Fortress Biotech, Inc. | 165.93 Million USD | -629.569% |
| Lantern Pharma Inc. | 2.73 Million USD | -44089.034% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -1593.675% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -34208.114% |
| Incyte Corporation | 1.59 Billion USD | 23.968% |
| IO Biotech, Inc. | 17.55 Million USD | -6795.87% |
| Jaguar Health, Inc. | 45.86 Million USD | -2539.513% |
| Novavax, Inc. | 2.57 Billion USD | 52.935% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -3257.477% |
| Opthea Limited | 264.6 Million USD | -357.533% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -826.224% |
| ContextLogic Inc. | 206 Million USD | -487.689% |
| MiMedx Group, Inc. | 96.33 Million USD | -1156.762% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -2421.009% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -34206.539% |
| NextCure, Inc. | 14.99 Million USD | -7972.541% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -29851.484% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -18031.481% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -2490.212% |
| Vaxcyte, Inc. | 167.44 Million USD | -622.99% |
| PDS Biotechnology Corporation | 33.25 Million USD | -3540.02% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -414.697% |
| Pharming Group N.V. | 244.07 Million USD | -396.015% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -10054.664% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -847.359% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -18222.807% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -18222.807% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -1368.634% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -18124.281% |
| Acelyrin, Inc. | 86.35 Million USD | -1301.965% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -93080.48% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -8319.494% |
| Summit Therapeutics Inc. | 125.25 Million USD | -866.524% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -12671.801% |
| Senti Biosciences, Inc. | 52.57 Million USD | -2202.865% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -1660.238% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -699.038% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -61793.609% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -90546.274% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -433.716% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -12824.512% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -432.278% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -144.816% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -10992.533% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -4300.563% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -9901.397% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -148.795% |
| Immix Biopharma, Inc. | 3.72 Million USD | -32428.468% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -3101.732% |
| MEI Pharma, Inc. | 8.35 Million USD | -14389.994% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -4072.459% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -248.305% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -729.949% |
| Fortress Biotech, Inc. | 165.93 Million USD | -629.569% |
| Precigen, Inc. | 41.64 Million USD | -2807.115% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -2324.673% |
| AlloVir, Inc. | 45.01 Million USD | -2589.412% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -828.853% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -778.548% |
| ImmuCell Corporation | 18.81 Million USD | -6334.427% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -4189.092% |
| Onconetix, Inc. | 23.18 Million USD | -5122.574% |
| PureTech Health plc | 125.58 Million USD | -864.015% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -13426.693% |
| Elevation Oncology, Inc. | 34.28 Million USD | -3431.413% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -49414.888% |
| Seer, Inc. | 39.36 Million USD | -2975.42% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -1857.886% |
| Innoviva, Inc. | 568.55 Million USD | -112.934% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -4346.302% |
| ESSA Pharma Inc. | 3.49 Million USD | -34538.467% |
| GlycoMimetics, Inc. | 6.9 Million USD | -17440.221% |
| GT Biopharma, Inc. | 6.63 Million USD | -18151.756% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -357.899% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -344.619% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -1340.791% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -12286.321% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -4355.957% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -37430.198% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -1541.166% |
| Aptose Biosciences Inc. | 15.8 Million USD | -7558.055% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -10866.245% |
| Soligenix, Inc. | 7.27 Million USD | -16541.306% |
| Century Therapeutics, Inc. | 175.94 Million USD | -588.094% |
| Kura Oncology, Inc. | 51.66 Million USD | -2243.384% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -898.202% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -29192.015% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -18204.589% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -379.275% |
| Autolus Therapeutics plc | 263.9 Million USD | -358.737% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -11449.695% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -1262.396% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -2481.375% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -243.097% |
| GRI Bio, Inc. | 2.69 Million USD | -44788.357% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -149438.22% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -3793.857% |
| IGM Biosciences, Inc. | 220.17 Million USD | -449.848% |
| INmune Bio, Inc. | 18.86 Million USD | -6318.402% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -372.023% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -4444.132% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -44434.886% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -36806.733% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -1971.062% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -1158.997% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -357.302% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -47.096% |
| Verastem, Inc. | 71.18 Million USD | -1600.694% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -2361.849% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -3038.159% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -2374.125% |
| Histogen Inc. | 5.69 Million USD | -21150.465% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -27504.834% |
| Surrozen, Inc. | 8.14 Million USD | -14763.585% |
| Organovo Holdings, Inc. | 2.74 Million USD | -43955.277% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -385628.259% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -2053.017% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -7231.874% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -2269.017% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -146311.368% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -855.328% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -11095.533% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -702.337% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -46331.868% |
| Apollomics, Inc. | 14.15 Million USD | -8453.939% |
| Amarin Corporation plc | 279.58 Million USD | -333.01% |
| Mesoblast Limited | 188.79 Million USD | -541.235% |
| Turnstone Biologics Corp. | 14.14 Million USD | -8456.962% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -569.646% |
| Synaptogenix, Inc. | 5.52 Million USD | -21794.308% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -18110.575% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -611.688% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -14047.618% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -68788.348% |
| Exelixis, Inc. | 678.44 Million USD | -78.443% |
| Better Therapeutics, Inc. | 23.84 Million USD | -4977.758% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -637.988% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -103.74% |
| NLS Pharmaceutics AG | 10.68 Million USD | -11235.355% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -74464.367% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -3010.024% |
| Gritstone bio, Inc. | 125.91 Million USD | -861.443% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -8149.107% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -23691.074% |
| Avid Bioservices, Inc. | 275.66 Million USD | -339.166% |
| Insmed Incorporated | 1.66 Billion USD | 27.147% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -15634.796% |
| MediWound Ltd. | 27.18 Million USD | -4353.007% |
| OmniAb, Inc. | 87.4 Million USD | -1285.17% |
| Alector, Inc. | 487.66 Million USD | -148.25% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -200.067% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -6470.632% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -3054.924% |
| Zai Lab Limited | 240.17 Million USD | -404.061% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -92.147% |
| Aura Biosciences, Inc. | 29.22 Million USD | -4042.194% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -1173.325% |
| Immunic, Inc. | 25.36 Million USD | -4672.308% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -1648.569% |
| Veracyte, Inc. | 93.71 Million USD | -1191.775% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -46166.347% |
| FibroGen, Inc. | 585.72 Million USD | -106.69% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -6864.5% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -185274.903% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -21306.56% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 84.188% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -14667.492% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -1340.86% |
| TG Therapeutics, Inc. | 169.08 Million USD | -615.994% |
| Galecto, Inc. | 5.89 Million USD | -20433.226% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -14514.184% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 53.764% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -4100.399% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -9492.259% |
| XBiotech Inc. | 8.39 Million USD | -14317.518% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -8149.107% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -2176.493% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -233.412% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -4403.195% |
| Theravance Biopharma, Inc. | 169 Million USD | -616.337% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 0.408% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -141.922% |
| Vaxxinity, Inc. | 30.94 Million USD | -3812.355% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -24.489% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -19973.247% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -62.451% |
| NexImmune, Inc. | 5.08 Million USD | -23711.64% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -325871.61% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -39272.32% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 82.966% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -23389.173% |
| Scopus BioPharma Inc. | 7.45 Million USD | -16140.522% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -4504.241% |
| Ainos, Inc. | 7.39 Million USD | -16272.768% |
| Pluri Inc. | 34.11 Million USD | -3449.012% |
| Prothena Corporation plc | 135.01 Million USD | -796.657% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -397.994% |
| Celularity Inc. | 102.92 Million USD | -1076.188% |
| Rallybio Corporation | 9.43 Million USD | -12730.002% |
| Cue Biopharma, Inc. | 24.44 Million USD | -4852.502% |
| MeiraGTx Holdings plc | 319.99 Million USD | -278.335% |
| Omeros Corporation | 403.25 Million USD | -200.219% |
| Humacyte, Inc. | 114.67 Million USD | -955.695% |
| Immunocore Holdings plc | 228.15 Million USD | -430.614% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -24733.621% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -1477.585% |
| Blueprint Medicines Corporation | 918.64 Million USD | -31.786% |
| CalciMedica, Inc. | 4.02 Million USD | -29955.586% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -6836.964% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -685.4% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -1310.722% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -335.806% |
| Pulmatrix, Inc. | 15.96 Million USD | -7484.032% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -7575.388% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -4820.097% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -382.696% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -2283.804% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -3709.077% |
| Nutriband Inc. | 1.07 Million USD | -112108.516% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -11285.677% |
| Vor Biopharma Inc. | 59.1 Million USD | -1948.32% |
| Roivant Sciences Ltd. | 773.95 Million USD | -56.423% |
| Evogene Ltd. | 17.99 Million USD | -6629.511% |
| ProKidney Corp. | 29.21 Million USD | -4043.753% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -1581.934% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -171625.985% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 35.908% |
| CorMedix Inc. | 11.91 Million USD | -10058.474% |
| BioLineRx Ltd. | 50.7 Million USD | -2287.754% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -710.014% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -1268.866% |
| Atai Life Sciences N.V. | 49.16 Million USD | -2362.55% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -3786.194% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -6640.001% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -871.34% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -21312.08% |
| MediciNova, Inc. | 3.89 Million USD | -31009.405% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -6523.114% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -80381.718% |
| GeoVax Labs, Inc. | 3.51 Million USD | -34294.316% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -204.748% |
| Biomea Fusion, Inc. | 30.69 Million USD | -3844.734% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 55.52% |
| Mereo BioPharma Group plc | 15.96 Million USD | -7484.507% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -3780.129% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -1962.98% |
| Absci Corporation | 58.3 Million USD | -1976.425% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -6255.728% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -3675.931% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -1540.655% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -1283.856% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -3484.954% |
| Allakos Inc. | 74.79 Million USD | -1518.653% |
| Imunon, Inc. | 8.53 Million USD | -14092.009% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -5280.379% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -954.453% |
| BioAtla, Inc. | 48.98 Million USD | -2371.398% |
| NLS Pharmaceutics AG | 10.68 Million USD | -11235.355% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -43463.836% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -826.954% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -8416.63% |
| XOMA Corporation | 145.58 Million USD | -731.597% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -3496.135% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -1660.699% |
| aTyr Pharma, Inc. | 31.59 Million USD | -3731.5% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -1858.234% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -2592.403% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -2401.217% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -42082.544% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -14739.867% |
| Akari Therapeutics, Plc | 4.58 Million USD | -26310.1% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -6726.99% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 26.604% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -299631.374% |
| UroGen Pharma Ltd. | 243.52 Million USD | -397.135% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -277.044% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -43738.985% |
| Orgenesis Inc. | 35.53 Million USD | -3306.892% |
| Entera Bio Ltd. | 1.37 Million USD | -87691.08% |
| GH Research PLC | 6.7 Million USD | -17966.542% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -17703.515% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -6330.676% |
| Xencor, Inc. | 283.55 Million USD | -326.944% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -40448.251% |
| Replimune Group, Inc. | 113.21 Million USD | -969.337% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -32122.484% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -1069.361% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -299631.374% |
| Portage Biotech Inc. | 4.45 Million USD | -27105.371% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -80381.718% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -5152.23% |
| OncoCyte Corporation | 49.29 Million USD | -2355.757% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -29165.073% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -151707.309% |
| Purple Biotech Ltd. | 10 Million USD | -12000.34% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -20823.591% |
| scPharmaceuticals Inc. | 57.26 Million USD | -2014.247% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -9672.659% |
| HilleVax, Inc. | 78.9 Million USD | -1434.222% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -23873.05% |
| Tharimmune, Inc. | 1.81 Million USD | -66600.183% |
| Genprex, Inc. | 3.25 Million USD | -37102.262% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -4364.173% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -23021.448% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -587588.835% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -337550.468% |
| OKYO Pharma Limited | 7.42 Million USD | -16214.029% |
| Savara Inc. | 37.19 Million USD | -3155.106% |
| Curis, Inc. | 57.61 Million USD | -2001.366% |
| Daré Bioscience, Inc. | 26.32 Million USD | -4497.971% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -2988.381% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -83739.266% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -5715.068% |
| BeiGene, Ltd. | 2.23 Billion USD | 45.802% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -5586.474% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -361.377% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -5590.698% |
| Erasca, Inc. | 78.61 Million USD | -1440.038% |
| bluebird bio, Inc. | 424.62 Million USD | -185.108% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -184659.299% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 35.947% |
| DBV Technologies S.A. | 42.8 Million USD | -2728.596% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -184659.299% |
| Moderna, Inc. | 4.57 Billion USD | 73.521% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -17207.205% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -73006.22% |
| Molecular Templates, Inc. | 31.17 Million USD | -3783.863% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -6992.203% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -105.855% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -872.362% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -4312.432% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -3220.822% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -2076.038% |
| MacroGenics, Inc. | 154.2 Million USD | -685.074% |
| RenovoRx, Inc. | 4.46 Million USD | -27007.904% |
| Adicet Bio, Inc. | 37.12 Million USD | -3161.42% |
| Prime Medicine, Inc. | 60.78 Million USD | -1891.838% |
| Aditxt, Inc. | 28.53 Million USD | -4143.158% |
| Adagene Inc. | 45.16 Million USD | -2580.223% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -669868.069% |
| Quantum-Si incorporated | 26.63 Million USD | -4445.976% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -73.552% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -39691.739% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -953.087% |
| SciSparc Ltd. | 1.59 Million USD | -75802.132% |
| Vericel Corporation | 127.7 Million USD | -847.997% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -21654.934% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -1318.306% |
| Generation Bio Co. | 171.63 Million USD | -605.377% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -10381.723% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -2794.119% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -379.085% |
| Invivyd, Inc. | 51.71 Million USD | -2241.073% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -1216.241% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -18510.181% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -1503.58% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -118473.849% |
| 2seventy bio, Inc. | 310.12 Million USD | -290.37% |
| ADMA Biologics, Inc. | 193.97 Million USD | -524.118% |
| Clene Inc. | 38.95 Million USD | -3008.108% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -3250.521% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -371.11% |
| GeoVax Labs, Inc. | 3.51 Million USD | -34294.316% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -536.298% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -9839.841% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -510.441% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -9827.502% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -2416.346% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -2191.098% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -227.329% |
| Evaxion Biotech A/S | 17.61 Million USD | -6771.806% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -652.281% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -690.307% |
| Trevena, Inc. | 48.26 Million USD | -2408.473% |
| Surrozen, Inc. | 8.14 Million USD | -14763.585% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -5506.108% |
| Cingulate Inc. | 10.36 Million USD | -11584.729% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -43923.236% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -3146.377% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -33655.256% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -9106.38% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -281.663% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -4771.983% |
| Clearmind Medicine Inc. | 3.61 Million USD | -33435.632% |
| Kronos Bio, Inc. | 54.2 Million USD | -2133.61% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -2473.473% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -5219.215% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -5931.782% |
| Statera Biopharma, Inc. | 22.67 Million USD | -5238.749% |
| ImmunityBio, Inc. | 1.09 Billion USD | -11.028% |
| Korro Bio, Inc. | 51.75 Million USD | -2239.309% |
| Kineta, Inc. | 7.22 Million USD | -16663.21% |
| BioVie Inc. | 9.7 Million USD | -12378.074% |
| Codexis, Inc. | 49.94 Million USD | -2323.896% |
| Celularity Inc. | 102.92 Million USD | -1076.188% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -1157.846% |
| Celcuity Inc. | 51.45 Million USD | -2253.036% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -350612.643% |
| Cibus, Inc. | 206.11 Million USD | -487.355% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -2750.239% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -4496.374% |
| IN8bio, Inc. | 8.77 Million USD | -13701.174% |
| Kodiak Sciences Inc. | 213.59 Million USD | -466.802% |
| Annexon, Inc. | 47.11 Million USD | -2469.377% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -1252.05% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -1156.214% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -8743.882% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 53.498% |
| Eyenovia, Inc. | 19.78 Million USD | -6020.434% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -583.645% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -15661.476% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -4923.607% |
| Arcellx, Inc. | 339.75 Million USD | -256.33% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -10075.147% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -393.052% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -12559.615% |
| Moolec Science SA | 13.94 Million USD | -8581.306% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -2705.522% |
| Geron Corporation | 146.12 Million USD | -728.484% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -2295.787% |
| Royalty Pharma plc | 6.29 Billion USD | 80.776% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -2943.642% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -411114.106% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -49107.327% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -540.021% |
| Humacyte, Inc. | 114.67 Million USD | -955.695% |
| Structure Therapeutics Inc. | 29.05 Million USD | -4067.288% |
| 89bio, Inc. | 59.96 Million USD | -1918.977% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -4474.837% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -101123.997% |
| Genelux Corporation | 8.42 Million USD | -14278.135% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -17558.095% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -788.093% |
| Notable Labs, Ltd. | 4.42 Million USD | -27246.713% |
| Liquidia Corporation | 73.13 Million USD | -1555.28% |
| Mustang Bio, Inc. | 17.61 Million USD | -6771.213% |
| Immunovant, Inc. | 48.95 Million USD | -2372.963% |
| Quantum-Si incorporated | 26.63 Million USD | -4445.976% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -3054.102% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -38915.114% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -1539.077% |
| Acasti Pharma Inc. | 11.55 Million USD | -10375.374% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -5254.978% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -44434.886% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -3182.911% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -88731.941% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -19759.564% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -4774.729% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -5121.873% |
| PepGen Inc. | 34.63 Million USD | -3395.825% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -9869.03% |
| United Therapeutics Corporation | 1.18 Billion USD | -2.406% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -17234.464% |
| Solid Biosciences Inc. | 38.45 Million USD | -3047.951% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -14047.618% |
| Immuneering Corporation | 12 Million USD | -9981.639% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -385628.259% |
| Silo Pharma, Inc. | 1.56 Million USD | -77046.635% |
| Belite Bio, Inc | 4.21 Million USD | -28649.442% |
| XOMA Corporation | 145.58 Million USD | -731.597% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -49761.573% |
| Bionomics Limited | 10.15 Million USD | -11817.238% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -5533.237% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -5183.634% |
| uniQure N.V. | 624.01 Million USD | -94.007% |
| Cassava Sciences, Inc. | 14.19 Million USD | -8428.63% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -669868.069% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -611.371% |
| Forte Biosciences, Inc. | 3.66 Million USD | -32923.432% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -464488.634% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -17843.367% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -15661.476% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -6864.5% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -11355.706% |
| Altimmune, Inc. | 16.54 Million USD | -7219.019% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -95.99% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -5183.634% |
| Compugen Ltd. | 55.77 Million USD | -2070.576% |
| Peak Bio, Inc. | 20.75 Million USD | -5733.459% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -995.968% |
| Benitec Biopharma Inc. | 4.96 Million USD | -24298.206% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -666.989% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -1510.449% |
| Zura Bio Limited | 21.29 Million USD | -5585.887% |
| PolyPid Ltd. | 17.46 Million USD | -6830.61% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -977.091% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -1510.449% |
| Instil Bio, Inc. | 99.8 Million USD | -1113.053% |
| argenx SE | 444.95 Million USD | -172.084% |
| Immunome, Inc. | 28.65 Million USD | -4124.436% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -14421.279% |
| Verona Pharma plc | 58.84 Million USD | -1957.475% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -8264.81% |
| Shattuck Labs, Inc. | 14.85 Million USD | -8047.513% |
| CervoMed Inc. | 2.59 Million USD | -46539.33% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -24738.716% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -9405.645% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -11391.59% |
| Moolec Science SA | 13.94 Million USD | -8581.306% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -51559.353% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -2077.593% |
| AnaptysBio, Inc. | 364.28 Million USD | -232.332% |
| Design Therapeutics, Inc. | 11.95 Million USD | -10025.786% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -9444.615% |
| NeurAxis, Inc. | 1.91 Million USD | -63193.476% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -3009.944% |
| Lumos Pharma, Inc. | 13.33 Million USD | -8980.02% |
| Achilles Therapeutics plc | 19.08 Million USD | -6242.741% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -8264.81% |
| 180 Life Sciences Corp. | 5.38 Million USD | -22372.471% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -5032.438% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -5219.215% |
| Nutriband Inc. | 1.07 Million USD | -112108.516% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -3856.595% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -8242.905% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -201.699% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -3628.14% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -9177.57% |
| Palisade Bio, Inc. | 2.73 Million USD | -44100.037% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -22946.621% |
| Beam Therapeutics Inc. | 478.38 Million USD | -153.068% |
| Neurogene Inc. | 36.54 Million USD | -3212.372% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -204.218% |
| AEON Biopharma, Inc. | 159.88 Million USD | -657.175% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -2440.69% |
| Sesen Bio, Inc. | 30.98 Million USD | -3807.304% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -4563.299% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -15824.817% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -518.5% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -530.354% |
| Athira Pharma, Inc. | 30.05 Million USD | -3927.81% |
| Vaccinex, Inc. | 5.94 Million USD | -20274.268% |
| HCW Biologics Inc. | 15.05 Million USD | -7943.075% |
| XOMA Corporation | 145.58 Million USD | -731.597% |
| Nektar Therapeutics | 267.04 Million USD | -353.345% |
| Arvinas, Inc. | 644.6 Million USD | -87.812% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -6726.99% |
| Merus N.V. | 102.15 Million USD | -1085.146% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -727.222% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -1172.749% |
| Rezolute, Inc. | 11.73 Million USD | -10217.36% |
| Clene Inc. | 38.95 Million USD | -3008.108% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -42417.648% |
| BeyondSpring Inc. | 48.26 Million USD | -2408.109% |
| Synlogic, Inc. | 32.89 Million USD | -3580.313% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -8184.671% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -73990.514% |
| Peak Bio, Inc. | 20.75 Million USD | -5733.459% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -1807.75% |
| Krystal Biotech, Inc. | 39.71 Million USD | -2948.394% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -221.428% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -1115.879% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -279670.34% |
| MannKind Corporation | 721.36 Million USD | -67.826% |
| Ikena Oncology, Inc. | 22.33 Million USD | -5320.367% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -57936.385% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -1080.075% |
| Gossamer Bio, Inc. | 249.14 Million USD | -385.914% |
| CohBar, Inc. | 1.03 Million USD | -117024.08% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -11226.027% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -6255.728% |
| Legend Biotech Corporation | 589.93 Million USD | -105.216% |
| Mural Oncology plc | 37.92 Million USD | -3091.94% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -812.753% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -52643.525% |
| Disc Medicine, Inc. | 22.87 Million USD | -5192.411% |
| Champions Oncology, Inc. | 28.03 Million USD | -4218.313% |
| REGENXBIO Inc. | 262.22 Million USD | -361.674% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -35937.873% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -9558.84% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -8913.346% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -5609.215% |
| Vaxart, Inc. | 34.02 Million USD | -3458.087% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -5837.63% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -4143.11% |
| Cellectis S.A. | 249.57 Million USD | -385.08% |
| Longeveron Inc. | 5.33 Million USD | -22583.886% |
| Repare Therapeutics Inc. | 41.81 Million USD | -2794.95% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 49.667% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -1905.432% |
| Revolution Medicines, Inc. | 262.39 Million USD | -361.377% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -57357.95% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -13934.767% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -10158.783% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -8520.943% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -56182.613% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 76.492% |
| Denali Therapeutics Inc. | 122.96 Million USD | -884.556% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -21654.934% |
| Veru Inc. | 32.81 Million USD | -3589.543% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -17524.676% |
| Cingulate Inc. | 10.36 Million USD | -11584.729% |
| Passage Bio, Inc. | 39.26 Million USD | -2983.488% |
| Context Therapeutics Inc. | 4.19 Million USD | -28781.711% |
| Exicure, Inc. | 8.54 Million USD | -14061.177% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -4002.748% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -11445.289% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -5392.668% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -642.787% |
| Nuvalent, Inc. | 31.82 Million USD | -3704.289% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -18930.336% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -1820.978% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -6625.772% |
| OmniAb, Inc. | 87.4 Million USD | -1285.17% |
| Anew Medical, Inc. | 8.24 Million USD | -14589.014% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -3061.838% |
| Lipocine Inc. | 2.63 Million USD | -45903.407% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -4508.096% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -2910.641% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -4444.132% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -1305.203% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -22315.09% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -1363.061% |
| Ocugen, Inc. | 23.98 Million USD | -4947.905% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -2508.742% |
| Q32 Bio Inc. | 233.12 Million USD | -419.302% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -13253.618% |
| Alumis Inc. Common Stock | 53.5 Million USD | -2162.792% |
| Equillium, Inc. | 27.95 Million USD | -4230.361% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -486.005% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -21416.102% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -19639.855% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -669.51% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -1643.608% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -12037.704% |
| Dominari Holdings Inc. | 4.63 Million USD | -26019.504% |
| Edesa Biotech, Inc. | 1.84 Million USD | -65637.113% |
| vTv Therapeutics Inc. | 29.56 Million USD | -3994.562% |
| Bio-Techne Corporation | 744.34 Million USD | -62.646% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -860.07% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -251.464% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -2883.707% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -4080.816% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -1210.783% |
| Nkarta, Inc. | 105.6 Million USD | -1046.438% |
| BioCardia, Inc. | 4.59 Million USD | -26275.577% |
| Iterum Therapeutics plc | 32.66 Million USD | -3606.567% |